DXCM 69.55 (-0.5%)
US2521311074Medical Diagnostics & ResearchDiagnostics & Research

DexCom (DXCM) Competitor Comparison

We are evaluating the key criteria listed to compare DexCom (DXCM) against its competitors in the Diagnostics & Research industry.

Performance 3 years - DXCM ranking 28 / 58

These are the competitors of DexCom in the industry Diagnostics & Research ranked by performance 3 years
1. Lantheus Holdings LNTH
374.38
2. Meridian Bioscience VIVO
246.63
3. RadNet RDNT
142.93
4. Medpace Holdings MEDP
85.11
5. Heska HSKA
41.31
6. PerkinElmer PKI
21.19
7. Natera NTRA
14.45
8. Ortho Clinical Diagnostics Holdings OCDX
13.74
9. Icon ICLR
11.69
10. Mettler-Toledo MTD
5.21
11. Quest Diagnostics DGX
4.7
12. Waters WAT
4.68
13. Thermo Fisher Scientific TMO
2.7
14. Danaher DHR
1.88
15. IQVIA Holdings IQV
-4.94
16. Agilent Technologies A
-5.06
17. Laboratory Corp of America Holdings LH
-9.24
18. Bioventus BVS
-12.73
19. Qiagen QGEN
-14.05
20. Syneos Health SYNH
-19.01
21. Myriad Genetics MYGN
-21.84
22. Olink Holding OLK
-22.2
23. IDEXX Laboratories IDXX
-22.81
24. Exact Sciences EXAS
-24.16
25. Anixa Biosciences ANIX
-31.75
26. Sera Prognostics SERA
-36.65
27. Sotera Health SHC
-40.57
28. DexCom DXCM
-47.21
29. CareDx CDNA
-50.61
30. Charles River Laboratories CRL
-52.5
31. Twist Bioscience TWST
-54.32
32. National Research NRC
-55.74
33. MaxCyte MXCT
-63.47
34. Illumina ILMN
-63.51
35. Neogen NEOG
-65.04
36. Global Cord Blood CO
-67.25
37. NeoGenomics NEO
-67.46
38. Enzo Biochem ENZ
-71.5
39. Psychemedics PMD
-72.22
40. Personalis PSNL
-74.46
41. Fulgent Genetics FLGT
-75.8
42. Interpace Biosciences IDXG
-76.41
43. bioAffinity Technologies BIAF
-77.26
44. Biodesix BDSX
-78.36
45. Exagen XGN
-78.88
46. Guardant Health GH
-79.37
47. Trinity Biotech TRIB
-81.98
48. MDxHealth MDXH
-83.54
49. Co-Diagnostics CODX
-84.85
50. Precipio PRPO
-86.88
51. Organovo Holdings ONVO
-89.19
52. Neuronetics STIM
-91.07
53. Pacific Biosciences of California PACB
-92.04
54. DarioHealth DRIO
-93.77
55. Inotiv NOTV
-94.56
56. SeqLL SQL
-95.69
57. Prenetics Global PRE
-96.26
58. Aspira Womens Health AWH
-98.83

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.